Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug ...

SIGN UP for TheStreet’s FREE Daily newsletter 💰💸 With the growing popularity of weight loss drugs like Ozempic, Wegovyn, Mounjaro, and Trulicity, food companies are joining in on this latest trend ...

The US Food and Drug Administration (FDA) has issued warning letters to four companies selling unapproved glucagon-like peptide-1 receptor agonist (GLP-1RA) products, as the agency continues its ...

There are more than 300 GLP-1Rs in an active stage of development, from industry giants and potential market disrupters.

At the moment that’s uncommon because diabetics and their carers are often reluctant to prepare current glucagon products so they generally need to be administered by a healthcare professional.

Both products are priced at a similar level to the glucagon injection kits available on the market, with a list price of $280 per dose, and in the US Xeris has partnered with Amazon’s PillPack ...

The US Food and Drug Administration approved a generic once-daily injectable version of the glucagon-like peptide-1 receptor ...

Objective—Glucagon-like peptide 1 (GLP-1) exerts beneficial antidiabetic actions via effects on pancreatic β- and α-cells. Previous studies have focused on the improvements in β-cell function ...